Le Lézard
Classified in: Health
Subjects: PER, DIS

New Vista Announces Leadership Transition


LEXINGTON, Ky., Jan. 20, 2020 /PRNewswire/ -- New Vista today announced the retirement of Paul R. Beatrice as Chief Executive Officer at the end of 2020. 

Linda Watt, New Vista Board of Directors Chair observed that, "During Paul's tenure as CEO, New Vista has met the challenges of an ever-changing healthcare landscape while staying true to our mission to serve Kentuckians who have limited resources to meet their behavioral health needs. New Vista is well-positioned for sustainability and future growth as the result of Paul's dedication and innovative leadership."

New Vista is one of the largest behavioral health providers in Kentucky, offering more than 106 programs in 55 locations. Beatrice was named CEO in February 2014. He has more than 35 years of experience in behavioral health leadership. Under Beatrice's leadership, staff grew 53% to employ more than 2,000 Kentuckians who provide mental health, substance use and intellectual and developmental disability services to more than 25,000 children, adults and families annually.

Beatrice expanded on his announcement by noting that "New Vista's role is a vital one. There remains a stigma associated with mental health and substance use services that we need to overcome. Our work will continue to address the public health needs in these areas and work to break down those barriers and help people reach their full potential. The staff at New Vista improves the lives of so many, and I am proud of our many accomplishments over the years. During this period of transition, I along with the executive team, will continue to do good work, create new programs and live our mission."

A national search for a new CEO at New Vista will begin immediately. The process is expected to take several months, with Beatrice's successor likely to be determined and announced prior to Beatrice's departure.

About New Vista
New Vista serves children, adults and families in Central Kentucky with services in mental health, substance use and intellectual and developmental disabilities. The mission of New Vista is to assist individuals and families in the enhancement of their emotional, mental and physical well-being. New Vista serves the community and particularly those who have limited options for meeting their behavioral health needs. For more information, visit www.newvista.org. For support and services, call New Vista's 24-Hour Helpline at 1.800.928.8000.                    

Media Contact:  Bethany Langdon
[email protected] 
859-253-1686 

SOURCE New Vista


These press releases may also interest you

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...

at 12:06
Burrell College of Osteopathic Medicine (BCOM) attained the highest level of accreditation from the American Osteopathic Association (AOA) Commission on Osteopathic College Accreditation (COCA). Burrell has been awarded the prestigious accreditation...

at 12:05
Radiance Biopharma ("Radiance" or the "Company"), a biopharmaceutical company specializing in the development of novel Antibody Drug Conjugates (ADCs) and Bispecific ADCs (BsADCs) treatments for cancers, today announced that...



News published on and distributed by: